A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS

被引：5

作者：

Buti, M. ^{[1
]}

Gane, E. ^{[2
]}

Seto, W. K. ^{[3
]}

Chan, H. L. Y. ^{[4
]}

Chuang, W. -L. ^{[5
]}

Stepanova, T. ^{[6
]}

Hui, A. J. ^{[7
]}

Lim, Y. -S. ^{[8
]}

Mehta, R. ^{[9
]}

Janssen, H. L. A. ^{[10
,11
]}

Acharya, S. K. ^{[12
]}

Flaherty, J. F. ^{[13
]}

Massetto, B. ^{[13
]}

Cathcart, A. ^{[13
]}

Dinh, P. ^{[13
]}

Subramanian, G. M. ^{[13
]}

McHutchison, J. G. ^{[13
]}

Pan, C. ^{[14
]}

Brunetto, M. ^{[15
]}

Izumi, N. ^{[16
]}

Marcellin, P. ^{[17
]}

机构：

[1] Hosp Gen Univ Vall dHebron, Barcelona, Spain

[2] Auckland Clin Studies, Auckland, New Zealand

[3] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China

[4] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[5] Kaoshing Med Univ Hosp, Kaoshing, Taiwan

[6] Modern Med Clin, Moscow, Russia

[7] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China

[8] Asan Med Ctr, Seoul, South Korea

[9] Nirmal Hosp Private Ltd, Surat, India

[10] Toronto Western Hosp, Toronto, ON, Canada

[11] Erasmus MC, Rotterdam, Netherlands

[12] All India Inst Med Sci, New Delhi, India

[13] Gilead Sci, Foster City, CA USA

[14] New Discovery LLC, Flushing, NY USA

[15] Univ Hosp Pisa, Pisa, Italy

[16] Musashino Red Cross Hosp, Tokyo, Japan

[17] Hop Beaujon, Clichy, France

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)01637-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

GS06

引用

页码：S135 / S136

页数：2

共 50 条

[1] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-negative, chronic hepatitis B (CHB): Week 48 efficacy and safety results
Cheng, W.
Pianko, S.
Thompson, A.
Buti, M.
Gane, E.
Seto, W. K.
Chan, H. L. Y.
Chuang, W-L
Stepanova, T.
Hui, A-J
Lim, Y-S
Mehta, R.
Janssen, H.
Acharya, S. K.
Flaherty, J. F.
Massetto, B.
Cathcart, A.
Dinh, P.
Subramanian, G. M.
Mchutchison, J. G.
Pan, C.
Brunetto, M.
Izumi, N.
Marcellin, P.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 68 - 69
[2] A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96
Brunetto, M.
Lim, Y. S.
Gane, E.
Seto, W. K.
Osipenko, M.
Ahn, S. H.
Janssen, H. L.
Shukla, A.
Chuang, W. L.
Trinh, H.
Celen, M. K.
Flaherty, J. F.
Lau, A. H.
Gaggar, A.
Suri, V.
Bhardwaj, N.
Kim, K.
Subramanian, G. M.
Pan, C.
Izumi, N.
Marcellin, P.
Chan, H.
Buti, M.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S25 - S26
[3] A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HBV: WEEK 48 EFFICACY AND SAFETY RESULTS
Chan, H. L. Y.
Fung, S.
Seto, W. K.
Chuang, W. -L.
Chen, C. -Y.
Kim, H. J.
Hui, A. J.
Janssen, H. L. A.
Chowdhury, A.
Tsang, T. Y. O.
Mehta, R.
Gane, E.
Flaherty, J. F.
Massetto, B.
Kitrinos, K.
Dinh, P.
Subramanian, G. M.
McHutchison, J. G.
Lim, Y. -S.
Acharya, S. K.
Agarwal, K.
JOURNAL OF HEPATOLOGY, 2016, 64 : S161 - S161
[4] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-NEGATIVE, CHRONIC HEPATITIS B PATIENTS: A GLOBAL PHASE 3 STUDY
Brunetto, Maurizia Rossana
Lim, Young-Suk
Gane, Edward
Seto, Wai-Kay
Osipenko, Marina
Ahn, Sang Hoon
Janssen, Harry L.
Shukla, Akash
Chuang, Wan-Long
Trinh, Huy N.
Celen, Mustafa
Flaherty, John F.
Chan, Alain
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Subramanian, Mani
Pan, Calvin Q.
Izumi, Namiki
Marcellin, Patrick
Chan, Henry L.
Buti, Maria
GASTROENTEROLOGY, 2017, 152 (05) : S1086 - S1086
[5] Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay Walter
Agarwal, Kosh
Brunetto, Maurizia R.
Janssen, Harry L. A.
Caruntu, Florin
Stepanova, Tatjana
Tsang, Owen
Yatsuhashi, Hiroshi
Tak, Won Young
Chen, Chi-Yi
Celen, Mustafa
Suri, Vithika
Flaherty, John F.
Lin, Lanjia
Cathcart, Andrea
Gaggar, Anuj
Pan, Calvin Q.
Shalimar
Buti, Maria
HEPATOLOGY, 2018, 68 : 227A - 228A
[6] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive chronic HBV (CHB): Week 48 efficacy and safety results
Strasser, S.
Roberts, S.
Angus, P.
Chan, H. L. Y.
Fung, S.
Seto, W. K.
Chuang, W. L.
Chen, C. Y.
Kim, H. J.
Hui, A. J.
Janssen, H. L. A.
Chowdhury, A.
Tsang, T. Y. O.
Mehta, R.
Gane, E.
Flaherty, J. F.
Massetto, B.
Kitrinos, K.
Dinh, P.
Subramanian, G. M.
Mchutchison, J. G.
Lim, Y. S.
Acharya, S. K.
Agarwal, K.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 82 - 82
[7] A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
Agarwal, K.
Fung, S.
Seto, W. K.
Lim, Y. S.
Gane, E.
Janssen, H. L.
Sharma, M.
Chuang, W. L.
Bae, H.
Yoon, K. T.
Flaherty, J. F.
Lau, A.
Gaggar, A.
Suri, V.
Cathcart, A.
Lin, L.
Subramanian, G. M.
Shalimar
Furusyo, N.
Buti, M.
Chan, H. L.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S478 - S478
[8] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
Agarwal, Kosh
Fung, Scott
Seto, Wai-Kay
Lim, Young-Suk
Gane, Edward
Janssen, Harry L.
Chuang, Wan-Long
Bae, Ho
Yoon, Ki Tae
Flaherty, John F.
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Cathcart, Andrea
Lin, Lanjia
Chan, Alain
Shalimar, Mani Subramanian
Furusyo, Norihiro
Buti, Maria
Chan, Henry L.
GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086
[9] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
Yu, N. Y.
Chang, K. C.
VALUE IN HEALTH, 2020, 23 : S532 - S532
[10] Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis B
Tseng, Cheng-Hao
Lee, Teng-Yu
Chen, Chi-Yi
Huang, Chung-Feng
Chen, Po-Yueh
Jang, Tyng-Yuan
Yang, Tzeng-Huey
Wu, Chia-Ching
Hsu, Yao-Chun
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025,

← 1 2 3 4 5 →